DTHC/F CELEBRATES NEWS THAT LONG-ACTING INJECTABLE PrEP IS SAFE AND EFFECTIVE IN PREVENTING HIV INFECTION IN AFRICAN WOMEN
10 November 2020 – The Desmond Tutu HIV Centre and Health Foundation welcome the announcement that another trial of long-acting injectable antiretroviral cabotegravir has demonstrated safety and efficacy in the prevention of HIV in cisgender women in Africa. Study sponsors ViiV, NIAID and the HPTN announced yesterday that the randomised part of the landmark trial…
Details